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Table 1
Genomic Disorders
• Duplicons comprise ∼5%–10% of human genome sequence
• Many current gaps in sequence may be duplicons
• Dozens of genetic diseases are genomic disorders
• Genetic disease load due to genomic disorders: at least
1/1,000 births as de novo events
• Many more genomic diseases to be identified by directed
approaches
• Wealth of knowledge began as 1 disease and 1 small, local
segmental duplication, barely 1 decade ago
It is my honor to introduce the 2002 Curt Stern Awardee,
Dr. James R. Lupski, for his ground-breaking work in
the initial identification and subsequent characterization
of genomic disorders. Jim first coined the term “genomic
disorders” to refer to those genetic diseases in which the
basis is a chromosome structural alteration due to ho-
mologous recombination between flanking low-copy re-
peat (LCR) sequences (Lupski 1998). These LCRs, also
called “duplicons” to distinguish them from dispersed,
common repetitive elements and short tandem repeat
elements in the genome (Eichler 1998), are region spe-
cific and derived by local genomic duplications that have
been evolutionarily fixed. In most instances, the pheno-
typic consequences of genomic disorders arise due to
deletion or duplication of one or more dosage-sensitive
genes within the chromosome region undergoing rear-
rangement, and Jim’s work has illustrated this for several
genomic disorders associated with chromosome 17p
subregions.
Clearly, the significance of this group of disorders is
illuminated by the recognition that duplicons comprise
∼5%–10% of human genome sequence distributed in a
nonrandom pattern within all human chromosomes (Bai-
ley et al. 2002) and that there are dozens of different
genetic diseases that are genomic disorders (table 1; Lup-
ski 1998; Ji et al. 2000; Emanuel and Shaikh 2001; Stan-
kiewicz and Lupski 2002). Indeed, at least 1 of every
1,000 births is a new mutation due to this recombination
mechanism (Ji et al. 2000; Shaffer and Lupski 2000).
With completion of the human genome sequence and
with future directed analysis of genes surrounded by
duplicons and their potential involvement in develop-
mental disorders and psychiatric conditions, these num-
bers are likely to increase further. Nevertheless, the cur-
rent wealth of knowledge began with just one disease
and the identification of one small duplicon (or LCR)
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barely 1 decade ago, and it is for his major role in
the key discovery of the chromosome 17p12 dupli-
cation in Charcot-Marie-Tooth syndrome type 1A
(CMT1A) (Lupski et al. 1991; Pentao et al. 1992), as
well as for his subsequent outstanding work in the field
of genomic disorders, that Jim is being recognized with
this award.
James R. Lupski, M.D., Ph.D., is the Cullen Professor
of Molecular and Human Genetics and Professor of
Pediatrics at Baylor College of Medicine in Houston,
Texas, where he has built a distinguished career since
1986. In his award presentation, Dr. Lupski will elab-
orate upon the paths that led him and his colleagues to
their discoveries in genomic disorders (Lupski 2003).
True to the goals of the award, the 2002 Curt Stern
Award is presented to Dr. James R. Lupski for his insight
and body of work illuminating the importance of ge-
nomic disorders and the mechanisms underlying homo-
logous recombination events due to genomic architec-
ture that explain many human diseases.
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